P Trenkwalder

Summary

Affiliation: Starnberg Hospital
Country: Germany

Publications

  1. ncbi request reprint Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination
    P Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Starnberg, Germany
    Blood Press 17:13-21. 2008
  2. ncbi request reprint Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination
    P Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Starnberg, Germany
    Blood Press Suppl 2:13-21. 2008
  3. ncbi request reprint Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination
    P Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Starnberg, Germany
    Blood Press Suppl 17:13-21. 2008
  4. ncbi request reprint [Therapy of hypertension in the elderly]
    P Trenkwalder
    Klinikum Starnberg, Akad Lehrkrankenhaus der Ludwig Maximilians Universität München
    Dtsch Med Wochenschr 131:1675-8. 2006
  5. ncbi request reprint The Study on COgnition and Prognosis in the Elderly (SCOPE)--recent analyses
    Peter Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich, Starnberg, Germany
    J Hypertens Suppl 24:S107-14. 2006
  6. ncbi request reprint The Study on COgnition and Prognosis in the Elderly (SCOPE) - major CV events and stroke in subgroups of patients
    Peter Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich, Osswaldstrasse 1, D 82319 Starnberg, Germany
    Blood Press 14:31-7. 2005
  7. ncbi request reprint [Is one antihypertensive agent as good as another?]
    Peter Trenkwalder
    Medizinische Klinik Klinikum Starnberg Osswaldstr 1, 82319 Starnberg
    MMW Fortschr Med 144:41-2. 2002
  8. ncbi request reprint Antihypertensive treatment with calcium channel blockers: pharmacological pornography or useful intervention?
    Peter Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich, Osswaldstrasse 1, D 82319 Starnberg, Germany
    Nephrol Dial Transplant 19:17-20. 2004
  9. ncbi request reprint Antihypertensive treatment with felodipine but not with a diuretic reduces episodes of myocardial ischaemia in elderly patients with hypertension
    P Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich Teaching Hospital, Germany
    Eur Heart J 15:1673-80. 1994
  10. ncbi request reprint Felodipine or hydrochlorothiazide/triamterene for treatment of hypertension in the elderly: effects on blood pressure, hypertensive heart disease, metabolic and hormonal parameters
    P Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich, Germany
    Blood Press 5:154-63. 1996

Detail Information

Publications23

  1. ncbi request reprint Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination
    P Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Starnberg, Germany
    Blood Press 17:13-21. 2008
    ....
  2. ncbi request reprint Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination
    P Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Starnberg, Germany
    Blood Press Suppl 2:13-21. 2008
    ....
  3. ncbi request reprint Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination
    P Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Starnberg, Germany
    Blood Press Suppl 17:13-21. 2008
    ..The combination of amlodipine 10 mg and valsartan 160 mg was well tolerated...
  4. ncbi request reprint [Therapy of hypertension in the elderly]
    P Trenkwalder
    Klinikum Starnberg, Akad Lehrkrankenhaus der Ludwig Maximilians Universität München
    Dtsch Med Wochenschr 131:1675-8. 2006
  5. ncbi request reprint The Study on COgnition and Prognosis in the Elderly (SCOPE)--recent analyses
    Peter Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich, Starnberg, Germany
    J Hypertens Suppl 24:S107-14. 2006
    ..Results in other subgroups were generally consistent with those in the entire SCOPE study population. In patients with slightly low cognitive function at baseline, the MMSE score declined less in the candesartan group...
  6. ncbi request reprint The Study on COgnition and Prognosis in the Elderly (SCOPE) - major CV events and stroke in subgroups of patients
    Peter Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich, Osswaldstrasse 1, D 82319 Starnberg, Germany
    Blood Press 14:31-7. 2005
    ..However, the benefit was particularly pronounced in patients who entered the study with a previous stroke...
  7. ncbi request reprint [Is one antihypertensive agent as good as another?]
    Peter Trenkwalder
    Medizinische Klinik Klinikum Starnberg Osswaldstr 1, 82319 Starnberg
    MMW Fortschr Med 144:41-2. 2002
  8. ncbi request reprint Antihypertensive treatment with calcium channel blockers: pharmacological pornography or useful intervention?
    Peter Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich, Osswaldstrasse 1, D 82319 Starnberg, Germany
    Nephrol Dial Transplant 19:17-20. 2004
  9. ncbi request reprint Antihypertensive treatment with felodipine but not with a diuretic reduces episodes of myocardial ischaemia in elderly patients with hypertension
    P Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich Teaching Hospital, Germany
    Eur Heart J 15:1673-80. 1994
    ..03), the total number of ST-D remained unchanged with the diuretic (non-significant increase from 31 to 45 episodes; P = 0.24). The same trend was observed for the number of patients with ST-D.(ABSTRACT TRUNCATED AT 250 WORDS)..
  10. ncbi request reprint Felodipine or hydrochlorothiazide/triamterene for treatment of hypertension in the elderly: effects on blood pressure, hypertensive heart disease, metabolic and hormonal parameters
    P Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich, Germany
    Blood Press 5:154-63. 1996
    ....
  11. ncbi request reprint Combination therapy with AT(1)-receptor blockers
    P Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich, Germany
    J Hum Hypertens 16:S17-25. 2002
    ....
  12. ncbi request reprint Potential for antihypertensive treatment with an AT(1)-receptor blocker to reduce dementia in the elderly
    P Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich, Germany
    J Hum Hypertens 16:S71-5. 2002
    ..SCOPE should provide important information on the long-term effects of AT(1)-receptor blocker treatment with candesartan on morbidity-including effects on cognitive function-and cardiovascular mortality in elderly hypertensive patients...
  13. ncbi request reprint Plasma renin activity and plasma prorenin are not suppressed in hypertensives surviving to old age
    P Trenkwalder
    Department of Internal Medicine, Starnberg Hospital, Ludwig Maximilian University Munich, Germany
    Am J Hypertens 9:621-7. 1996
    ..The wide spectrum of plasma renin levels in the elderly indicates that treatment of these patients too can profitably be guided by pretreatment plasma renin levels...
  14. doi request reprint The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League
    Stephan Lüders
    Department of Internal Medicine, St Josefs Hospital, Cloppenburg, Germany
    J Hypertens 26:1487-96. 2008
    ....
  15. ncbi request reprint Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study
    Heinrich Holzgreve
    Kardiologische Praxis, Munich, Germany
    Curr Med Res Opin 22:1849-58. 2006
    ..Tight blood pressure (BP) control is required to reduce cardiovascular morbidity and mortality...
  16. ncbi request reprint Cognitive function and health-related quality of life in elderly patients with hypertension--baseline data from the study on cognition and prognosis in the elderly (SCOPE)
    Alessio degl'Innocenti
    AstroZeneca R and D, Molndal, Sweden
    Blood Press 11:157-65. 2002
    ..Age and the use of psychotropic drugs, but not gender and education level, influenced this relationship significantly...
  17. ncbi request reprint Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapy
    Jean Michel Mallion
    Department de Cardiologie et Hypertension Artérielle, CHU Grenoble, France
    Blood Press Suppl 1:36-43. 2003
    ..5) once daily (o.d.) and Val 160/hydrochlorothiazide 25 mg (Val 160/HCTZ 25) o.d. vs Val 160 o.d. monotherapy in patients with mild-to-moderate essential hypertension not adequately controlled with valsartan monotherapy...
  18. ncbi request reprint Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)
    Ingmar Skoog
    Institute of Clinical Neurosciences, Neuropsychiatric Epidemiology Unit, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden
    Am J Hypertens 18:1052-9. 2005
    ..We examined whether cognitive function at baseline affected cognitive and cardiovascular outcomes in the Study on COgnition and Prognosis in the Elderly (SCOPE), a blood pressure (BP)-lowering intervention trial...
  19. ncbi request reprint [A therapeutically delicate duo. Hypertension and COPD (interview by Dr. med. Jochen Aumiller)]
    Peter Trenkwalder
    MMW Fortschr Med 147:41-2. 2005
  20. ncbi request reprint Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE)
    Vasilios Papademetriou
    Hypertension and Cardiovascular Research, Veterans Administration Medical Center, Washington, DC 20422, USA
    J Am Coll Cardiol 44:1175-80. 2004
    ..The aim of this study was to test the hypothesis that the angiotensin II type 1 receptor blocker (ARB) candesartan can reduce the risk of stroke in elderly patients with isolated systolic hypertension (ISH)...
  21. ncbi request reprint Therapy in the elderly hypertensive
    Peter A Meredith
    University Department of Medicine and Therapeutics, The Western Infirmary, Glasgow, G11 6NT, UK pam
    J Renin Angiotensin Aldosterone Syst 3:S49-56. 2002
  22. ncbi request reprint The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial
    Hans Lithell
    Department of Public Health and Caring Sciences, Sections of Geriatrics Clinical Hypertension Research and Family Medicine, University of Uppsala, Uppsala, Sweden
    J Hypertens 21:875-86. 2003
    ..The prognostic benefits of blood pressure lowering treatment in elderly hypertensive patients were established more than a decade ago, but are less clear in those with mildly to moderately elevated blood pressure...
  23. ncbi request reprint The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization
    Hans Lithell
    Department of Public Health and Caring Sciences, Section of Geriatrics, University of Uppsala, Sweden
    J Hypertens 22:1605-12. 2004
    ..e. in patients that best reflect the original intention of a placebo-controlled trial...